Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation reports news as a medical device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets. Company updates commonly cover sales trends, organic growth, product-line performance, adjusted earnings measures, debt and leverage, and outlook commentary tied to customer programs and new product activity.
Integer news also includes governance and capital-allocation developments, including board composition, shareholder engagement, share repurchase authorization, investor conference participation, and broader strategy updates. The company’s public identity includes the Greatbatch Medical and Lake Region Medical brands and engineering and manufacturing work for medical device customers.
Integer (NYSE: ITGR) announced that its Board has initiated a strategic review to evaluate a full range of options, including a sale, merger, or strategic business combination versus continued standalone execution.
The Board cited strong interest received, appointed Goldman Sachs & Co. LLC as financial advisor and Davis Polk & Wardwell LLP as legal advisor, and set no timeline or assurance that a transaction will occur.
Integer Holdings (NYSE:ITGR) reported Q1 2026 results: sales $440 million (+0.5%), organic sales +1.3%, GAAP income from continuing operations $17 million (+173%), and adjusted operating income $61 million (down 14%).
The Board initiated a strategic review to maximize stockholder value; 2026 outlook provided with GAAP and non-GAAP ranges and leverage guidance of 2.5x–3.5x.
Integer (NYSE: ITGR) will participate in the 2026 Bank of America Healthcare Conference, May 12-14, 2026, with a fireside chat on May 12 at 1:40 p.m. PT. A live webcast and replay will be available on Integer's Investor Relations News & Events page at investor.integer.net.
Integer (NYSE: ITGR) announced a planned board leadership transition. Independent Chair Pamela G. Bailey will not stand for re-election at the May 20, 2026 Annual Meeting. Following the meeting, the Board intends to appoint director Donald J. Spence as independent Chair.
Mr. Spence has served on the Board since 2016, chairs the Compensation & Organization Committee and sits on two other committees; Ms. Bailey thanked colleagues and endorsed the succession.
Integer (NYSE: ITGR) will webcast a conference call to discuss financial results and business highlights for the first quarter ended April 3, 2026. The call is scheduled for Thursday, April 30, 2026 at 8 a.m. CT (9 a.m. ET), following a news release of results earlier that day.
Dial-in numbers, Conference ID 3120125, webcast registration and an audio replay available for seven days will be provided via the company's Investor Relations website.
Integer (NYSE: ITGR) appointed James Flanagan and Aaron Kapito to its Board of Directors effective March 12, 2026, adding financial, governance and risk‑management expertise.
The appointments follow a cooperation agreement with Irenic Capital Management; two existing directors will not stand for re‑election at the annual meeting.
Integer (NYSE: ITGR) announced its executive leadership will participate in three investor conferences in March 2026: Raymond James (11:35 a.m. ET, March 3), Oppenheimer (12:40 p.m. ET, March 17) and KeyBanc (11:15 a.m. ET, March 18).
According to Integer, each event will be available via live webcast and replay under Investor Relations > News & Events at investor.integer.net.
Integer (NYSE:ITGR) reported fourth-quarter and full-year 2025 results on Feb 19, 2026, with 2025 sales of $1.854 billion (up 8%) and adjusted EPS of $6.40 (up 21%). Integer generated $196 million of operating cash flow, repurchased ~698,356 shares for $50 million, and ended 2025 with $1.185 billion total debt (leverage 3.0x).
The company maintained its 2026 outlook midpoint, targeting adjusted EPS $6.29–$6.78 and reiterated a plan to return to ~200 bps above-market organic sales growth by 2027.
Integer (NYSE: ITGR) will exhibit at MD&M West 2026 in Anaheim, Feb 3–5, unveiling an expanded 20 x 50 sq. ft. booth #3201 and showcasing R&D Velocity, an integrated R&D ecosystem linking design, prototyping and manufacturing to accelerate device manufacturability.
Integer will also highlight expanded medical coatings capabilities after recent acquisitions, plus cardiac rhythm, neuromodulation, and cardio/vascular product platforms.
Integer (NYSE: ITGR) will webcast a conference call to discuss fourth quarter and full year results for the period ended Dec. 31, 2025, on Thursday, Feb. 19, 2026 at 8 a.m. CT / 9 a.m. ET.
The company will issue a news release with financial results prior to the call. Domestic dial-in: (800) 715-9871; international dial-in: (646) 307-1963; conference ID: 3120125. Webcast registration is available via the Integer investor site and an audio replay will be available for seven days by dialing (800) 770-2030 or (609) 800-9909 using the same conference ID. Live and archived replay will be on Integer's Investor Relations website.